-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
From December 19th to 20th, the Guangming Science City 2020 Engineering Bio Innovation Conference and the MIT Technology Review China Life Science Entrepreneurship Competition finals were held at the Guangming District Culture and Art Center of Shenzhen Guangming Science City
.
As the largest and highest-level conference in the field of synthetic biology in China, this conference has attracted dozens of top scientists, business leaders and representatives of investment institutions in the field of life sciences, especially in the field of synthetic biology, to discuss the development status of synthetic biology and its development.
huge impact on human society
.
Synthetic biology industry has significant opportunities
Synthetic biology industry has significant opportunities"Carbon neutrality" is a hot topic at this conference, and as an important achievement of synthetic biology, bio-based materials not only do not increase carbon emissions, but are also "carbon negative" materials
.
On December 12, a series of new measures for China's Nationally Determined Contribution were released: by 2030, China's carbon dioxide emissions per unit of GDP will drop by more than 65% compared with 2005, and the proportion of non-fossil energy in primary energy consumption will reach about 25%.
The forest stock volume will increase by 6 billion cubic meters compared with 2005, and the total installed capacity of wind power and solar power generation will reach more than 1.
2 billion kilowatts
.
Just the day before, leaders of the 27 EU countries passed the European Commission's proposal to increase the medium-term goal of achieving "carbon neutrality" at the EU Winter Summit, agreed on a higher emission reduction target, and decided to reduce the EU's greenhouse gas emissions by 2030.
It will be more than 55% less than in 1990, and achieve "carbon neutrality" by 2050
.
Industry insiders pointed out that the current carbon neutral approach that people are concerned about is mainly concentrated in the energy field, that is, the use of new energy to gradually replace fossil energy to reduce carbon emissions
.
The first is a technological breakthrough
.
The development of the synthetic biology industry must stand the test of large-scale industrialization
The development of the synthetic biology industry must stand the test of large-scale industrializationAt present, most of the companies in the field of synthetic biology are still in the growth stage.
Whether they can achieve large-scale industrialization is the key point for companies in the field of synthetic biology to break through
.
Liu Xiucai, chairman of Kasai Biotechnology and a core technical expert, said in his speech at the conference that for the synthetic biology industry, it is not enough for products to contribute to environmental protection.
The real development of the industry must solve the problem of industrialization.
The product can compete with traditional chemical method products in cost
.
In fact, a number of internationally renowned companies, including Metabolix, BioAmber, and Cobalt, are facing survival problems precisely because they cannot achieve industrialization
.
In 13 years, Kasai Biological has realized the substitution of biological long-chain dibasic acids for chemical products, and its product cost and performance have undoubtedly withstood the test of the market
.
After becoming the leading enterprise in the field of biological long-chain dibasic acids, Kasai Bio began to extend the downstream of the industrial chain and gradually added bio-based polyamide (nylon) products
.
Liu Xiucai believes that ideal materials for carbon emission reduction should have three characteristics: renewable raw materials, recyclable products, and competitive costs
.
Cathay Biotech has demonstrated the possibility of carbon emission reduction in the field of materials with the industrialization practice of bio-based polyamide materials
.
In October of this year, Kasai Biology cooperated with Shanxi to jointly invest to build the "Shanxi Synthetic Biology Industry Ecological Park"
.
Utilizing synthetic biology and clean energy, the material industrial park will achieve "zero carbon" and become the world's leading industrial cluster of 100 billion bio-based green new materials
.
